Cargando…

Searching for optimal blood pressure targets in type 2 diabetic patients with coronary artery disease

BACKGROUND: Controversies exist regarding the optimal blood pressure (BP) level that is safe and provides cardiovascular protection in patients with type 2 diabetes mellitus (T2DM) and coexistent coronary artery disease. Several new glucose-lowering agents have been found to lower BP as well, making...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Ying, Dai, Yang, Wang, Xiao Qun, Zhang, Rui Yan, Lu, Lin, Ding, Feng Hua, Shen, Wei Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858977/ https://www.ncbi.nlm.nih.gov/pubmed/31733658 http://dx.doi.org/10.1186/s12933-019-0959-1

Ejemplares similares

Donor artery stenosis interactions with diastolic blood pressure on coronary collateral flow in type 2 diabetic patients with chronic total occlusion
por: Shen, Ying, et al.
Publicado: (2018)

Reduced coronary collateralization in type 2 diabetic patients with chronic total occlusion
por: Shen, Ying, et al.
Publicado: (2018)

Diabetic dyslipidemia impairs coronary collateral formation: An update
por: Shen, Ying, et al.
Publicado: (2022)

High serum levels of N-epsilon-carboxymethyllysine are associated with poor coronary collateralization in type 2 diabetic patients with chronic total occlusion of coronary artery
por: Li, Le-Ying, et al.
Publicado: (2022)

Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus
por: Chen, Shuai, et al.
Publicado: (2021)

Impact of coronary collateralization on long-term clinical outcomes in type 2 diabetic patients after successful recanalization of chronic total occlusion
por: Yang, Zhen Kun, et al.
Publicado: (2020)

Serum Cystatin C Reflects Angiographic Coronary Collateralization in Stable Coronary Artery Disease Patients with Chronic Total Occlusion
por: Shen, Ying, et al.
Publicado: (2015)

Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion
por: Shen, Ying, et al.
Publicado: (2019)

The Ongoing Saga of Optimal Blood Pressure Level in Patients With Diabetes Mellitus and Coronary Artery Disease
por: Deedwania, Prakash
Publicado: (2018)

Optimal achieved blood pressure for patients with stable coronary artery disease
por: Huang, Chin-Chou, et al.
Publicado: (2017)

Visit-to-visit HbA(1c) variability is associated with in-stent restenosis in patients with type 2 diabetes after percutaneous coronary intervention
por: Yang, Chen Die, et al.
Publicado: (2020)

Clinical Utility of the Ratio Between Circulating Fibrinogen and Fibrin (ogen) Degradation Products for Evaluating Coronary Artery Disease in Type 2 Diabetic Patients
por: Xiong, Wei-Xin, et al.
Publicado: (2015)

Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus
por: Shen, Ying, et al.
Publicado: (2015)

Optimal oxygen and mean arterial blood pressure targets after cardiac arrest
por: Skrifvars, Markus B, et al.
Publicado: (2023)

Optimal perioperative management of arterial blood pressure
por: Lonjaret, Laurent, et al.
Publicado: (2014)

SerpinG1: A Novel Biomarker Associated With Poor Coronary Collateral in Patients With Stable Coronary Disease and Chronic Total Occlusion
por: Chen, Shuai, et al.
Publicado: (2022)

Increased glycated albumin and decreased esRAGE levels in serum are related to negative coronary artery remodeling in patients with type 2 diabetes: an Intravascular ultrasound study
por: Du, Run, et al.
Publicado: (2018)

Glycation of Apoprotein A-I Is Associated With Coronary Artery Plaque Progression in Type 2 Diabetic Patients
por: Pu, Li Jin, et al.
Publicado: (2013)

Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
por: Shen, Ying, et al.
Publicado: (2015)

Optimal blood pressure for patients with end‐stage renal disease following coronary interventions
por: Yang, Ya‐Ling, et al.
Publicado: (2021)

Gender-specific differences in associations between economic status and systolic blood pressure or diastolic blood pressure
por: Li, Jun, et al.
Publicado: (2020)

Increased blood glycohemoglobin A1c levels lead to overestimation of arterial oxygen saturation by pulse oximetry in patients with type 2 diabetes
por: Pu, Li Jin, et al.
Publicado: (2012)

Insulin resistance and dysglycemia are associated with left ventricular remodeling after myocardial infarction in non-diabetic patients
por: Yang, Chen Die, et al.
Publicado: (2019)

Visit-to-visit fasting plasma glucose variability is associated with left ventricular adverse remodeling in diabetic patients with STEMI
por: Yang, Chen Die, et al.
Publicado: (2020)

Data on the value of elevated circulating mimecan levels for detecting poor coronary collateralization in patients with stable angina and chronic total occlusion
por: Shen, Ying, et al.
Publicado: (2016)

The search for optimal blood pressure control in type 2 diabetes mellitus: have we found the holy grail?
por: Verbraecken, Johan
Publicado: (2020)

Association between visit‐to‐visit blood pressure variability and adverse events in coronary artery disease patients after coronary intervention
por: Tsai, Tsung‐Ying, et al.
Publicado: (2022)

Comparison of ambulatory blood pressure and clinic blood pressure in relation to cardiovascular diseases in diabetic patients
por: Shen, Jian, et al.
Publicado: (2017)

Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion
por: Shen, Ying, et al.
Publicado: (2013)

Value of serum glycated albumin and high-sensitivity C-reactive protein levels in the prediction of presence of coronary artery disease in patients with type 2 diabetes
por: Pu, Li Jin, et al.
Publicado: (2006)

The Optimal Blood Pressure Target in Different Dialysis Populations
por: Jhee, Jong Hyun, et al.
Publicado: (2018)

Relationship of High-Density Lipoprotein-Associated Arylesterase Activity to Systolic Heart Failure in Patients with and without Type 2 Diabetes
por: Li, Chang, et al.
Publicado: (2019)

Impact of Coronary Tortuosity on Coronary Pressure: Numerical Simulation Study
por: Li, Yang, et al.
Publicado: (2012)

Ambulatory blood pressure monitoring and blood pressure control in patients with coronary artery disease—A randomized controlled trial
por: Hägglund, Oscar, et al.
Publicado: (2020)

Intensive blood pressure treatment in coronary artery disease: implications from the Systolic Blood Pressure Intervention Trial (SPRINT)
por: Zang, Jiabin, et al.
Publicado: (2021)

Association of Circulating IgE and CML Levels with In-Stent Restenosis in Type 2 Diabetic Patients with Stable Coronary Artery Disease
por: Liu, Jingmeng, et al.
Publicado: (2022)

Clinical Implication of Coronary Tortuosity in Patients with Coronary Artery Disease
por: Li, Yang, et al.
Publicado: (2011)

Predictors of long-term absence of coronary artery calcium in individuals with high blood pressure: results from the MESA study
por: You, Si, et al.
Publicado: (2023)

The Role of Monocyte to High-Density Lipoprotein Cholesterol Ratio in Prediction of Carotid Intima-Media Thickness in Patients With Type 2 Diabetes
por: Chen, Jia Wei, et al.
Publicado: (2019)

Inspiration from strategy of blood pressure intervention in the elderly hypertensive patients for optimal blood pressure target
por: Wang, Xiaoqi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mq278una7di4gpu2tcrbsrh6s1